BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18392316)

  • 1. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
    Beyer T; Pietrzyk U; Knoess C; Vollmar S; Wienhard K; Kracht L; Bockisch A; Maderwald S; Kühl H; Fitzek M
    Nuklearmedizin; 2008; 47(2):73-9. PubMed ID: 18392316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
    Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
    Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
    Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
    Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
    J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
    Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
    Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
    Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma.
    Lucignani G; Paganelli G; Modorati G; Pieralli S; Rizzo G; Magnani P; Colombo F; Zito F; Landoni C; Scotti G
    J Comput Assist Tomogr; 1992; 16(1):77-83. PubMed ID: 1729312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.
    Calcagni ML; Mattoli MV; Blasi MA; Petrone G; Sammarco MG; Indovina L; Mulè A; Rufini V; Giordano A
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1682-91. PubMed ID: 23824464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
    Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
    Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
    Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
    Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.